Markus Thor (MBA, MSc)

 

Background

2009-              CEO & Senior Consultant at Thor Life Science Consulting AB

2009-2013     Chief Business Officer at Kancera AB (publ) and iNovacia AB

2006-2009     Vice President & Head, Business Development at Biovitrum AB (publ)

2003-2006     Director, Business Development at Biovitrum AB

2001-2003     Senior Scientist, R&D at Biovitrum AB

1994-2001     Medicinal Chemistry, R&D at Pharmacia Corp, Pharmacia & Upjohn Inc. and Pharmacia AB

 

Education

  • Executive MBA from Stockholm School of Economics
  • Certified Board Director at The Swedish Academy of Board Directors
  • MSc (Chemistry) from University of Umeå

 

Experience from a wide range of deal types:

  • In-licensing
  • Out-licensing
  • FTO licenses
  • Mergers & Acquisitions
  • Co-development
  • Co-promotion
  • Research collaborations
  • Option agreements
  • Service agreements
  • Etc.

Experienced with term sheet and contract negotiations with wide range of countries and cultures and have closed deals in USA, Europe and Asia.

Experience from a range of therapeutic areas:

  • Cancer
  • Ophthalmology
  • Metabolic diseases
  • Inflammation
  • Pain
  • Infectious disease
  • Etc.

Experience from a range of technologies:

  • Small molecules
  • Biologics
  • Vaccines
  • Nanotechnology
  • Diagnostics